-+ 0.00%
-+ 0.00%
-+ 0.00%

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga·11/14/2025 17:06:24
Listen to the news

Gainers

  • Cidara Therapeutics (NASDAQ:CDTX) stock rose 105.6% to $217.94 during Friday's regular session. The company's market cap stands at $3.3 billion.
  • Cypherpunk Technologies (NASDAQ:CYPH) shares increased by 72.42% to $3.03. The company's market cap stands at $99.7 million.
  • Traws Pharma (NASDAQ:TRAW) stock increased by 51.89% to $2.69. The market value of their outstanding shares is at $12.6 million. The company's, Q3 earnings came out yesterday.
  • Invivyd (NASDAQ:IVVD) stock increased by 44.06% to $2.55. The market value of their outstanding shares is at $370.5 million.
  • Oncology Institute (NASDAQ:TOI) stock rose 33.92% to $4.12. The company's market cap stands at $287.9 million. The company's, Q3 earnings came out yesterday.
  • Precigen (NASDAQ:PGEN) shares moved upwards by 29.6% to $5.0. The market value of their outstanding shares is at $1.3 billion. As per the news, the Q3 earnings report came out yesterday.

Losers

  • enVVeno Medical (NASDAQ:NVNO) shares decreased by 38.3% to $0.4 during Friday's regular session. The company's market cap stands at $13.2 million.
  • Anavex Life Sciences (NASDAQ:AVXL) shares decreased by 29.88% to $3.99. The market value of their outstanding shares is at $488.7 million.
  • Palatin Techs (AMEX:PTN) shares declined by 18.74% to $8.78. The company's market cap stands at $18.3 million. As per the news, the Q1 earnings report came out yesterday.
  • Zynex (NASDAQ:ZYXI) stock decreased by 16.2% to $0.65. The company's market cap stands at $23.5 million.
  • Clearmind Medicine (NASDAQ:CMND) stock declined by 16.12% to $0.29. The market value of their outstanding shares is at $2.1 million.
  • RenovoRx (NASDAQ:RNXT) shares decreased by 15.57% to $0.82. The company's market cap stands at $35.7 million. As per the press release, Q3 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.